Table 2

*Groups*					*Parameters*
Zileuton treated	Montelukast treated	PC	AC	NC	*Parameters*
0.798 ± 0.0164**	0.752 ± 0.0164**	0.52 ± 0.013	0.568 ± 0.024*	1.102 ± 0.0258	Plasma GSH (mmol/L)
0.229 ± 0.0117**	0.254 ± 0.0107**	0.51 ± 0.0142	0.51 ± 0.0145*	0.133 ± 0.005	Plasma MDA(µmol/L)
62.3 ± 1.69**	67.7 ± 1.94**	135.9 ± 2.09	135.3 ± 1.4*	32.9 ± 0.88	Plasma hsCRP (µg/L)

*p < 0.05, as compare to NC group, **p < 0.05, as compare to AC group

Table 2: Change in mean plasma levels of hs-CRP, MDA and GSH among the five study groups.